Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63234 1503498110HCLSReviewIndonesiaAugust2017.pdf
Energy Boardroom

Targeted Therapy in NSCLC Part IV: ALK

27.05.2014 / Thomson Reuters Blog

In the fourth in this series on targeted therapy in non small cell lung cancer (NSCLC) a new target has emerged recently: anaplastic lymphoma kinase (ALK). Also known as ALK tyrosine kinase receptor or CD246 (cluster of differentiation 246), the ALK gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. See […]

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: